止吐剂量地塞米松不影响非心脏手术肺部并发症:病理生理学问题?
本文针对Zorrilla-Vaca等人在Br J Anaesth发表的二次分析进行解读。该分析基于个体化围术期开放肺通气策略试验,发现止吐剂量地塞米松(4-8 mg i.v.)未降低非心脏手术患者术后肺部并发症(PPCs)风险。作者指出围术期肺不张而非全身炎症是PPCs主要驱动因素,强调设计预防策略时需区分复合结局的病理生理通路,并重申标准剂量地塞米松的安全性。
要点
- 止吐剂量地塞米松(4-8 mg i.v.)未降低非心脏手术患者PPCs风险。
- 围术期肺不张是PPCs关键驱动因素,主要取决于手术、全麻诱导和通气管理。
- 设计PPCs预防策略时需区分复合结局的病理生理通路,标准剂量地塞米松安全性已确立。
核心结论
- 止吐剂量地塞米松(4-8 mg i.v.)不降低非心脏手术患者PPCs风险,标准剂量安全性已确立。
研究设计与样本
- 基于个体化围术期开放肺通气策略试验的二次分析,由Zorrilla-Vaca等人在Br J Anaesth发表。
主要发现
- 止吐剂量地塞米松(4-8 mg i.v.)未减少患者PPCs风险。
- 围术期肺不张是PPCs关键驱动因素,主要取决于手术、全麻诱导和通气管理而非全身炎症。
临床怎么用
- 不应以预防PPCs为目的使用止吐剂量地塞米松,其标准剂量用于止吐是安全的。
- PPCs预防应关注肺不张相关因素如手术类型、全麻诱导和通气管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Postoperative pulmonary complications (PPCs) remain common and are exacerbated by perioperative systemic inflammation. Dexamethasone, administered to millions of patients each year for prophylaxis against postoperative nausea and vomiting, effectively attenuates systemic inflammatory responses, rendering it a plausible adjunct for PPC prevention. In a recent issue of the British Journal of Anaesthesia, Zorrilla-Vaca and colleagues present a well-designed secondary analysis of the individualised, perioperative open-lung ventilation strategy trials showing that antiemetic doses of dexamethasone (4-8 mg i.v.) did not reduce patients' risk of PPCs. In the underlying iPROVE (Individualised, Perioperative Open-Lung Ventilation Strategy) studies, other landmark trials, and clinical routine practice across general patient populations, the key driver and major contributor to PPCs is perioperative atelectasis, which is predominantly determined by surgery, induction of general anaesthesia, and ventilatory management rather than systemic inflammation. The findings by Zorrilla-Vaca and colleagues emphasise the importance of differentiating the pathophysiological pathway of composite clinical outcomes including PPCs when designing preventive strategies, while reaffirming the established safety of dexamethasone at standard doses.
引用
- Ahrens E, Schaefer MS. Antiemetic doses of dexamethasone do not affect pulmonary complications after noncardiac surgery: a matter of pathophysiology? Br J Anaesth. 2026. PMID: 42805888. doi:10.1016/j.bja.2026.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。